{"nct_id":"NCT05081388","title":"COVID-19 Study to Evaluate Safety, Tolerability, and Efficacy of REGN14256+Imdevimab for the Treatment of COVID-19 Adult and Adolescent Patients Without Risk Factors for Progression to Severe Disease","status":"TERMINATED","status_verified_date":"2023-11","start_date":"2021-11-08","start_date_type":"ACTUAL","primary_completion_date":"2022-06-30","primary_completion_date_type":"ACTUAL","completion_date":"2022-06-30","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["REGN"]}